XML 62 R49.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Revenues $ 581 $ 49,412 $ 25,324 $ 50,249
Less:        
Research and development 28,142 27,732 81,232 87,846
Impairment of long-lived assets 0 0 0 5,521
Stock-based compensation     6,949 9,099
Net (loss) income (34,930) 10,672 (85,513) (74,545)
Reportable Segment        
Segment Reporting Information [Line Items]        
Revenues 581 49,412 25,324 50,249
Less:        
Research and development 14,020 19,316 43,774 55,398
General and administrative 6,716 11,199 23,498 29,559
Clinical manufacturing operations 13,175 7,075 34,251 27,931
Impairment of long-lived assets 0 0 0 5,521
Stock-based compensation 2,127 3,315 6,949 9,099
Other segment items (527) (2,165) 2,365 (2,714)
Net (loss) income $ (34,930) $ 10,672 $ (85,513) $ (74,545)